NASDAQ : ACHV

Achieve Life Sciences, Inc. — Company profile

Healthcare · Biotechnology · United States

Last price 6.83 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 702.82M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a naturally occurring alkaloid that interacts with nicotine receptors in the brain that reduces the severity of nicotine withdrawal symptoms. It has license and supply agreements with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Details

NameAchieve Life Sciences, Inc.
SectorHealthcare
IndustryBiotechnology
Employees28
CeoAndrew Goldberg
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS0044685008
Cusip004468500
Cik0000949858
Sic2835
Stock TypeCommon Stock

Key executives

NameTitle
Dr. Andrew D. Goldberg M.D.Chief Executive Officer, President and Director
Erik AtkissonChief Legal Officer
Benjamin Halladay M.B.A.Chief Financial Officer
Jerry WanVice President of Finance and Principal Accounting Officer
Kaitlyn TusonSenior Vice President of Marketing and Communications
Dr. Mark L. Rubinstein M.D.Chief Medical Officer
Mark ZappiaSenior Vice President of Commercial
Ronald DadinoSenior Vice President of Chemistry, Manufacturing and Controls and Supply Chain
Gloria CosgroveSenior Vice President of Global Quality
Nicole P. JonesVice President of Strategic Communications and Stakeholder Relations

Contact

Address22722 29th Dr. SE, Suite 100, Bothell, Washington 98021, United States
Phone604 210 2217
Websitehttps://www.achievelifesciences.com